Paul Bolno - 01 Jan 2022 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Role
President and Chief Executive Officer, Director
Signature
/s/ Paul B. Bolno
Issuer symbol
WVE
Transactions as of
01 Jan 2022
Net transactions value
$0
Form type
4
Filing time
04 Jan 2022, 20:17:39 UTC
Previous filing
17 Jun 2021
Next filing
18 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WVE Share Option (right to buy) Award $0 +600,000 $0.000000 600,000 01 Jan 2022 Ordinary Shares 600,000 $3.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the shares on January 1, 2023 and vests as to an additional 6.25% of the shares quarterly thereafter until January 1, 2026.

Remarks:

President and Chief Executive Officer